Cost-effectiveness of adjunct non-pharmacological interventions for osteoarthritis of the knee

Background There is limited information on the costs and benefits of alternative adjunct non-pharmacological treatments for knee osteoarthritis and little guidance on which should be prioritised for commissioning within the NHS. This study estimates the costs and benefits of acupuncture, braces, heat treatment, insoles, interferential therapy, laser/light therapy, manual therapy, neuromuscular electrical stimulation, pulsed electrical stimulation, pulsed electromagnetic fields, static magnets and transcutaneous electrical nerve Stimulation (TENS), based on all relevant data, to facilitate a more complete assessment of value. Methods Data from 88 randomised controlled trials including 7,507 patients were obtained from a systematic review. The studies reported a wide range of outcomes. These were converted into EQ-5D index values using prediction models, and synthesised using network meta-analysis. Analyses were conducted including firstly all trials and secondly only trials with low risk of selection bias. Resource use was estimated from trials, expert opinion and the literature. A decision analytic model synthesised all evidence to assess interventions over a typical treatment period (constant benefit over eight weeks or linear increase in effect over weeks zero to eight and dissipation over weeks eight to 16). Results When all trials are considered, TENS is cost-effective at thresholds of £20–30,000 per QALY with an incremental cost-effectiveness ratio of £2,690 per QALY vs. usual care. When trials with a low risk of selection bias are considered, acupuncture is cost-effective with an incremental cost-effectiveness ratio of £13,502 per QALY vs. TENS. The results of the analysis were sensitive to varying the intensity, with which interventions were delivered, and the magnitude and duration of intervention effects on EQ-5D. Conclusions Using the £20,000 per QALY NICE threshold results in TENS being cost-effective if all trials are considered. If only higher quality trials are considered, acupuncture is cost-effective at this threshold, and thresholds down to £14,000 per QALY.

[1]  Alex J. Sutton,et al.  Heterogeneity: Subgroups, Meta-Regression, Bias And Bias-Adjustment , 2011 .

[2]  L. Curtis,et al.  Unit Costs of Health and Social Care 2016 , 2015 .

[3]  A. Sutton,et al.  Acupuncture and other physical treatments for the relief of pain due to osteoarthritis of the knee: network meta-analysis☆ , 2013, Osteoarthritis and cartilage.

[4]  K. Muir,et al.  Do estimates of cost-utility based on the EQ-5D differ from those based on the mapping of utility scores? , 2008, Health and quality of life outcomes.

[5]  K Claxton,et al.  Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development. , 2012, Health technology assessment.

[6]  D. Ashby,et al.  Topical or oral ibuprofen for chronic knee pain in older people. The TOIB study. , 2008, Health technology assessment.

[7]  Karl Claxton,et al.  Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold. , 2015, Health technology assessment.

[8]  Oliver Rivero-Arias,et al.  Estimating the Association between SF-12 Responses and EQ-5D Utility Values by Response Mapping , 2006, Medical decision making : an international journal of the Society for Medical Decision Making.

[9]  S D Walter,et al.  The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. , 1997, Journal of clinical epidemiology.

[10]  G. Lu,et al.  Combination of direct and indirect evidence in mixed treatment comparisons , 2004, Statistics in medicine.

[11]  M. Botteman,et al.  Estimating Preference-Based EQ-5D Health State Utilities or Item Responses from Neuropathic Pain Scores , 2012, The Patient - Patient-Centered Outcomes Research.

[12]  George Lewith,et al.  Acupuncture for chronic pain: individual patient data meta-analysis. , 2012, Archives of internal medicine.

[13]  A. Rangan,et al.  Management of frozen shoulder: a systematic review and cost-effectiveness analysis. , 2012, Health technology assessment.

[14]  D. Altman,et al.  The importance of allocation concealment and patient blinding in osteoarthritis trials: a meta-epidemiologic study. , 2009, Arthritis and rheumatism.

[15]  Joseph C Cappelleri,et al.  Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1. , 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[16]  F. Atamaz,et al.  Interferential Current Therapy in Patients with Knee Osteoarthritis: Comparison of the Effectiveness of Different Amplitude-Modulated Frequencies , 2012, American journal of physical medicine & rehabilitation.

[17]  M. Sculpher,et al.  Methods for network meta-analysis of continuous outcomes using individual patient data: a case study in acupuncture for chronic pain , 2016, BMC Medical Research Methodology.

[18]  A. Vickers,et al.  Influence of Control Group on Effect Size in Trials of Acupuncture for Chronic Pain: A Secondary Analysis of an Individual Patient Data Meta-Analysis , 2014, PloS one.

[19]  Deborah M Caldwell,et al.  Simultaneous comparison of multiple treatments: combining direct and indirect evidence , 2005, BMJ : British Medical Journal.

[20]  J. Tarro,et al.  Evaluating the benefits of patterned stimulation in the treatment of osteoarthritis of the knee: a multi-center, randomized, single-blind, controlled study with an independent masked evaluator. , 2008, Osteoarthritis and cartilage.

[21]  C. Bias.  The Cochrane Collaboration's tool for assessing risk of bias in randomised trials , 2011 .

[22]  A. Vickers,et al.  The persistence of the effects of acupuncture after a course of treatment: a meta-analysis of patients with chronic pain , 2017, Pain.

[23]  R. Geenen,et al.  EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis , 2013, Annals of the rheumatic diseases.

[24]  R. Adedoyin,et al.  Effect of Interferential Current Stimulation in Management of Osteo-arthritic Knee Pain , 2002 .

[25]  E. Long.  International Society for Pharmacoeconomics and Outcomes Research , 2012 .

[26]  Helen Dakin,et al.  Review of studies mapping from quality of life or clinical measures to EQ-5D: an online database , 2013, Health and Quality of Life Outcomes.

[27]  K Claxton,et al.  The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. , 1999, Journal of health economics.

[28]  Franziska Wulf,et al.  Methods For The Economic Evaluation Of Health Care Programmes , 2016 .

[29]  R. Brooks.  EuroQol: the current state of play. , 1996, Health policy.

[30]  J. Sterne,et al.  The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.

[31]  S. Wilson.  Methods for the economic evaluation of health care programmes , 1987 .

[32]  Donna Rowen,et al.  Mapping to obtain EQ-5D utility values for use in NICE health technology assessments. , 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[33]  M. Sculpher,et al.  Acupuncture for chronic pain and depression in primary care: a programme of research , 2017 .

[34]  Arden,et al.  EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT) , 2003, Annals of the rheumatic diseases.

[35]  John Brazier,et al.  Mapping SF-36 onto the EQ-5D index: how reliable is the relationship? , 2009, Health and quality of life outcomes.